The Guardian
Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines A drug that promotes muscle growth could significantly reduce the loss of lean body mass when using slimming jabs, research suggests. While GLP-1 based jabs such as Wegovy and Mounjaro have proved highly effective at helping people who are overweight or obese, experts have warned it is not only fat that is lost. Studies suggest 25-40% of total weight loss is down to a reduction in lean body mass – non-fat components of the body, including muscle. Continue reading...
Go to News Site